These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2533180

  • 21. [Comparison of the effectiveness of physical training with parenteral drug therapy in Fontaine stage IIb peripheral arterial occlusive disease].
    Streminski JA, de la Haye R, Rettig K, Kuntz G.
    Vasa; 1992; 21(4):392-402. PubMed ID: 1485475
    [Abstract] [Full Text] [Related]

  • 22. Defibrotide: properties and clinical use of an old/new drug.
    Pescador R, Capuzzi L, Mantovani M, Fulgenzi A, Ferrero ME.
    Vascul Pharmacol; 2013; 59(1-2):1-10. PubMed ID: 23680861
    [Abstract] [Full Text] [Related]

  • 23. [Prevention of thromboembolism in patients operated on for hip prosthesis].
    Cremonese M, Rigon N, Ratti G, Pojana A, Todesco A, Sartore A.
    Minerva Med; 1988 May; 79(5):367-72. PubMed ID: 3287226
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Successful treatment with defibrotide for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.
    Yakushijin K, Matsui T, Okamura A, Yamamoto K, Ito M, Chihara K.
    Kobe J Med Sci; 2005 May; 51(3-4):55-65. PubMed ID: 16444097
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Treadmill exercise-induced release of endothelin-1 in patients with peripheral arterial occlusive disease at Fontaine stage IIb.
    Mangiafico RA, Malatino LS, Spada RS, Santonocito M, Messina R, Dell'Arte S, Attinà T.
    Int Angiol; 2000 Mar; 19(1):14-7. PubMed ID: 10853680
    [Abstract] [Full Text] [Related]

  • 29. [Use of defibrotide in the treatment of acute superficial thrombophlebitis of the legs].
    Seccia M, Bortolotti P, Bellomini MG, Buccianti P, Chiarugi M, Cavina E.
    Minerva Chir; 1989 May 15; 44(9):1379-84. PubMed ID: 2761740
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Three-month therapy with calcium-heparin in comparison with ticlopidine in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Andreozzi GM, Signorelli SS, Cacciaguerra G, Di Pino L, Martini R, Monaco S, Buttò G, Sardina M.
    Angiology; 1993 Apr 15; 44(4):307-13. PubMed ID: 8457082
    [Abstract] [Full Text] [Related]

  • 33. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.
    Shah MS, Jeevangi NK, Joshi A, Khattry N.
    J Cancer Res Ther; 2009 Apr 15; 5(4):312-4. PubMed ID: 20160371
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A, De Martini D, Flore R, Gaetani E, Gasbarrini A, Gerardino L, Pola R, Santoliquido A, Serricchio M, Tondi P, Nolfe G.
    Drugs Exp Clin Res; 1999 Apr 15; 25(1):29-36. PubMed ID: 10337502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.